{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T03:29:45Z","timestamp":1772594985851,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T00:00:00Z","timestamp":1707868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013738","name":"Pacira Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.tube.2024.102482","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T12:16:12Z","timestamp":1707480972000},"page":"102482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Efficacies of three drug regimens containing omadacycline to treat Mycobacteroides abscessus disease"],"prefix":"10.1016","volume":"146","author":[{"given":"Binayak","family":"Rimal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandra M.","family":"Panthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel C.","family":"Belz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa H.","family":"Ignatius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher K.","family":"Lippincott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel H.","family":"Deck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alisa W.","family":"Serio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyanu","family":"Lamichhane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2024.102482_bib1","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41579-020-0331-1","article-title":"Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus","volume":"18","author":"Johansen","year":"2020","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.tube.2024.102482_bib2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fmicb.2018.00067","article-title":"Phylogenomics and comparative genomic studies robustly support division of the genus Mycobacterium into an emended genus Mycobacterium and four novel genera","volume":"9","author":"Gupta","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.tube.2024.102482_bib3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/microorganisms7030090","article-title":"Mycobacterium abscessus: Environmental bacterium turned clinical nightmare","volume":"7","author":"Lopeman","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.tube.2024.102482_bib4","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/jac\/dkr578","article-title":"Mycobacterium abscessus: a new antibiotic nightmare","volume":"67","author":"Nessar","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tube.2024.102482_bib5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/cid\/ciq237","article-title":"Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease","volume":"52","author":"Jarand","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tube.2024.102482_bib6","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1089\/mdr.2017.0286","article-title":"Activities of dual combinations of antibiotics against multidrug-resistant nontuberculous mycobacteria recovered from patients with cystic fibrosis","volume":"24","author":"Schwartz","year":"2018","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.tube.2024.102482_bib7","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1164\/rccm.201508-1586IM","article-title":"Biofilm Formation by Mycobacterium abscessus in a lung cavity","volume":"193","author":"Fennelly","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.tube.2024.102482_bib8","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1183\/13993003.01102-2015","article-title":"Chronic pulmonary disease with Mycobacterium abscessus complex is a biofilm infection","volume":"46","author":"Qvist","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.tube.2024.102482_bib9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.chest.2021.07.035","article-title":"Treatment of Mycobacterium abscessus pulmonary disease","volume":"161","author":"Griffith","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.tube.2024.102482_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ccm.2021.11.007","article-title":"Nontuberculous mycobacteria","volume":"43","author":"Varley","year":"2022","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.tube.2024.102482_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/thoraxjnl-2017-210929","article-title":"British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)","volume":"72","author":"Haworth","year":"2017","journal-title":"Thorax"},{"key":"10.1016\/j.tube.2024.102482_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01586-16","article-title":"Origins of combination therapy for tuberculosis: lessons for future antimicrobial development and application","volume":"8","author":"Kerantzas","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.tube.2024.102482_bib13","first-page":"273","article-title":"The emergence of isoniazid-resistant culture in patients with pulmonary tuberculosis during treatment with isoniazid alone or isoniazid plus PAS","volume":"31","author":"Selkon","year":"1964","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.tube.2024.102482_bib14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1473-3099(13)70328-1","article-title":"New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects","volume":"14","author":"Zumla","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tube.2024.102482_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101311","article-title":"Analysis of combination drug therapy to develop regimens with shortened duration of treatment for tuberculosis","volume":"9","author":"Drusano","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2024.102482_bib16","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1128\/AAC.01066-13","article-title":"Mechanism of action of the novel aminomethylcycline antibiotic omadacycline","volume":"58","author":"Draper","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2024.102482_bib17","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/AAC.01242-13","article-title":"In vitro and in vivo antibacterial activities of omadacycline, a novel aminomethylcycline","volume":"58","author":"Macone","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2024.102482_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02522-18","article-title":"In vitro activities of omadacycline against rapidly growing mycobacteria","volume":"63","author":"Shoen","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2024.102482_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.00470-19","article-title":"In vitro activity of new tetracycline analogs omadacycline and eravacycline against drug-resistant clinical isolates of Mycobacterium abscessus","volume":"63","author":"Kaushik","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2024.102482_bib20","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1093\/jac\/dkz267","article-title":"Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessus","volume":"74","author":"Bax","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tube.2024.102482_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01704-21","article-title":"Potency of omadacycline against Mycobacteroides abscessus clinical isolates in vitro and in a mouse model of pulmonary infection","volume":"66","author":"Nicklas","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2024.102482_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00665-22","article-title":"Efficacy of omadacycline-containing regimen in a mouse model of pulmonary Mycobacteroides abscessus disease","author":"Rimal","year":"2023","journal-title":"mSphere"},{"key":"10.1016\/j.tube.2024.102482_bib23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s40265-020-01257-4","article-title":"Omadacycline: a novel oral and intravenous aminomethylcycline antibiotic agent","volume":"80","author":"Zhanel","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.tube.2024.102482_bib24","article-title":"In Vitro susceptibility testing of omadacycline against nontuberculous mycobacteria (NTM)","author":"Brown-Elliott","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2024.102482_bib25","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/jac\/dkz523","article-title":"Repurposing drugs for treatment of Mycobacterium abscessus: a view to a kill","volume":"75","author":"Gumbo","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tube.2024.102482_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab002","article-title":"Preliminary, real-world, multicenter experience with omadacycline for Mycobacterium abscessus infections","volume":"8","author":"Morrisette","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.tube.2024.102482_bib27","first-page":"e5112","article-title":"Utilizing the promise of omadacycline in a resistant, non-tubercular mycobacterial pulmonary infection","volume":"11","author":"Minhas","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.tube.2024.102482_bib28","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/cid\/ciz1014","article-title":"Omadacycline in the treatment of Mycobacterium abscessus infection","volume":"71","author":"Madariaga","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tube.2024.102482_bib29","series-title":"M24 suppl","article-title":"Performance standards for susceptibility testing of Mycobacteria, Nocardia spp., and other Aerobic Actinomycetes","year":"2018"},{"key":"10.1016\/j.tube.2024.102482_bib30","first-page":"1","article-title":"A mouse model of pulmonary Mycobacteroides abscessus infection","volume":"10","author":"Maggioncalda","year":"2020","journal-title":"Nat Sci Reports"},{"key":"10.1016\/j.tube.2024.102482_bib31","first-page":"e00614","article-title":"Synergistic efficacy of \u03b2-lactam combinations against Mycobacterium abscessus pulmonary infection in mice","volume":"63","author":"Story-Roller","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2024.102482_bib32","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00536-22","article-title":"T405, a new penem, exhibits in vivo efficacy against M. abscessus and synergy with \u03b2-lactams imipenem and cefditoren","volume":"66","author":"Rimal","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2024.102482_bib33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/jid.1953.18","article-title":"An unusual acid-fast infection of the knee with subcutaneous, abscess-like lesions of the gluteal region","volume":"20","author":"Moore","year":"1953","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.tube.2024.102482_bib34","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02545-20","article-title":"\u03b2-lactam combinations that exhibit synergy against Mycobacteroides abscessus clinical isolates","volume":"65","author":"Story-Roller","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2024.102482_bib35","series-title":"Mol. Genet. Mycobact.","first-page":"313","article-title":"Some common methods in mycobacterial genetics","author":"Larsen","year":"2000"},{"key":"10.1016\/j.tube.2024.102482_bib36","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1128\/am.26.5.658-665.1973","article-title":"Microdilution antibiotic susceptibility test: examination of certain variables","volume":"26","author":"Tilton","year":"1973","journal-title":"Appl Microbiol"},{"key":"10.1016\/j.tube.2024.102482_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.00359","article-title":"Extreme drug tolerance of Mycobacterium abscessus \u201cpersisters\u201d","volume":"11","author":"Yam","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.tube.2024.102482_bib38","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1128\/JCM.01144-14","article-title":"Genome sequencing of Mycobacterium abscessus isolates from patients in the United States and comparisons to globally diverse clinical strains","volume":"52","author":"Davidson","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tube.2024.102482_bib39","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00090-23","article-title":"Novel synergies and isolate specificities in the drug interaction landscape of Mycobacterium abscessus","volume":"67","author":"Van","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2024.102482_bib40","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01579-22","article-title":"In vitro synergistic effects of omadacycline with other antimicrobial agents against Mycobacterium abscessus","volume":"67","author":"Fujiwara","year":"2023","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979224000088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979224000088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:47:55Z","timestamp":1761468475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979224000088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":40,"alternative-id":["S1472979224000088"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2024.102482","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacies of three drug regimens containing omadacycline to treat Mycobacteroides abscessus disease","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2024.102482","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102482"}}